NANOG and breast cancer: In contrast to the vector control group, the effective knockdown of EBF3 markedly suppressed the upregulated expression of Nanog, OCT4 and SOX2 in MCF-7 and T47D breast cancer cells that exhibited overexpression of SNORA47 (Fig. 3G-H).